New User:

Forgot your password?

Stock Market & Financial Investment News

News For ARAY;FINL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
19:01 EDTARAYOn The Fly: After Hours Movers
UP AFTER EARNINGS: Ellie Mae (ELLI), up 10%... Ocwen Financial (OCN), up 9%... athenahealth (ATHN), up 8.5%... Expedia (EXPE), up 4.5%... Skyworks Solutions (SWKS), up 3.7%... Eastman Chemical (EMN), up 2.4%... Nektar Therapeutics (NKTR), up 1.4%... FireEye (FEYE), up 2%. ALSO HIGHER: Monsanto (MON), up 3.6% following a Bloomberg report that the company approached Syngenta (SYT) about a takeover... Altera (ALTR), up 4.4% following a Reuters report that Intel (INTC) has a standstill pact set to end in June. DOWN AFTER EARNINGS: LinkedIn (LNKD), down 21.3%... Hutchinson Technology (HTCH), down 15.3%... Insulet (PODD), down 13.9%... Accuray (ARAY), down 14%... Constant Contact (CTCT), down 9.9%... Trimble Navigation (TRMB), down 6.6%... First Solar (FSLR), down 4.4%... JDS Uniphase (JDSU), down 3%... BioMarin (BMRN), down 1.8%... Visa (V), down 1.6%.
16:16 EDTARAYAccuray signs development agreement with MIM Software
Accuray Incorporated announced that it has signed an agreement with MIM Software Inc. to further develop adaptive therapy software for the TomoTherapy and CyberKnife product portfolios. The new software solution will leverage both Accuray and MIM technology. This is Accuray's second collaboration with MIM; the previous partnership led to the development of the first iPad-based treatment plan review capability, PlanTouch.
16:15 EDTARAYAccuray reports Q3 EPS (4c), consensus (6c)
Subscribe for More Information
09:35 EDTFINLFinish Line seen as an attractive target for private equity, says dealReporter
Subscribe for More Information
April 27, 2015
08:21 EDTFINLBofA/Merrill retail/consumer analysts hold analyst/industry conference call
Subscribe for More Information
April 21, 2015
07:14 EDTARAYAccuray initiates international commercial launch of InCise Multileaf Collimator
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use